Infusion Pumps Market Size, Share & Trends Analysis Report By Products (Insulin Infusion Pump, Large Volume Infusion Pump, Syringe Infusion Pump, Enteral Feeding Pump, Others), By Technology (Traditional Infusion Pumps, Specialty Infusion Pump), By Usage (Stationary Infusion Pump, Ambulatory Infusion Pump), By Applications (Diabetes, Oncology, Gastroenterology, Pediatric and Neonatology, Pain Management, Others), By End-Users (Hospital, Home Healthcare, Nursing Home, Others) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2025-2033

 Infusion Pumps Market Size

The global infusion pumps market size was valued at USD 15.35 billion in 2024 and is projected to reach from USD 16.66 billion in 2025 to USD 31.99 billion by 2033, growing at a CAGR of 8.50% during the forecast period (2025–2033). The increasing accessibility of alternative care providers has benefited the utilization rate of infusion pumps, driving market growth.

Infusion pumps are medical devices that deliver controlled quantities of fluids, such as nutrients and medications, into a patient's body. Although arterial, subcutaneous, and epidural infusions are occasionally used, they are administered intravenously. Fluids can be given in methods that would be prohibitively expensive or unreliable if done manually by nursing staff with infusion pumps. For instance, they can administer injections at a rate of 0.1 mL per hour (too slow for a drip), give injections every minute, give injections with repeated boluses at the patient's request, up to a maximum number per hour (for instance, in patient-controlled analgesia), or give fluids whose volumes vary throughout the day.

Infusion pumps are extensively utilized in numerous clinical settings, such as hospitals, home healthcare, and nursing homes. These units administer medication to patients requiring emergency care, oncology treatment, and pain management after surgery.

Infusion Pumps Market Growth Factors

Increasing presence of alternative care sites

The growing availability of alternative care services in recent years has positively influenced the application rate of infusion pumps. Infusion therapies and the demand for infusion pumps have also increased over the years due to the demand for home healthcare and alternative care solutions. Alternate sites for infusion therapies are known to reduce medical costs by almost 30%–45% compared to hospitals, which has triggered the demand for infusion pumps.

Factors such as flexible scheduling, high-quality medical care, and other services have also increased the preference for medical treatment facilities, such as alternate care sites (ACSs). The growing global burden of healthcare services, the expanding geriatric population, and the rising demand for chronic disease care drive the demand for alternate care sites and home-based healthcare services. All these factors are expected to spur market growth.

Rising surgical procedures and chemotherapy treatments 

Infusion pumps are the major factor in surgical procedures for anesthesia, which helps with temporary loss of sensation. More than 3,000 surgeries are performed per 100,000 population at a global level. The increasing frequency of surgical procedures due to the expanding geriatric population, increasing prevalence of chronic conditions associated with a sedentary lifestyle, and rising number of accidents drive the demand for surgeries, directly impacting the demand for infusion pumps.

The rise in the prevalence of various diseases has necessitated surgical procedures and anesthesia delivery, accounting for 11% of the disease burden in the global healthcare industry. The increasing rate of surgical procedures is driving the demand for infusion pumps. Approximately 5,000 surgeries are needed per year for a 100,000 population, which is expected to drive the demand for infusion pumps to eliminate medication errors.

Restraining Factors

Safety concerns associated with infusion pumps 

Drug administration is one of the major procedures in the healthcare industry, along with other high-cost services. Between 2020 and 2021, various authorities, such as the Institute for Safe Medication Practices (ISMP), issued reports and guidelines on using smart infusion pumps. Similarly, in 2021, the Joint Commission published the Sentinel Event Alert on smart infusion pumps.

Additionally, the rise in the frequency of product recalls for infusion pumps with numerous cases of medication errors has hampered the market growth. There has been a considerable increase in the recall of smart infusion pumps and other types of infusion pumps since 2017, which has proven to be a major growth impediment for the sales of new infusion pumps.

Market Opportunities

New multipurpose infusion pumps for disease treatments 

Smart infusion pumps have recently been used for multiple therapies in specific patient care areas. These infusion pump variants offer various benefits within a short period and a relatively lower expenditure across diverse clinical settings. Many hospitals have adopted innovative multipurpose and multi-therapy infusion pumps to reduce the work burden of their staff and minimize errors associated with medication delivery. Multipurpose infusion pumps are designed to enable accurate and timely delivery of several medications simultaneously, ensuring the treatment of two patients at a time.

• For instance, Caesarea Medical Electronic (CME) manufactures multiple multipurpose infusion and syringe pump systems. The company's BodyGuard 323 Color Vision is an advanced multi-therapy infusion pump mostly used in hospitals. These infusion pumps provide different infusion modes, such as continuity, patient control analgesia, Total Parenteral Nutrition (TPN), drugs library, and home parenteral nutrition. Such factors have generated a new opportunity for multipurpose infusion pumps in the market.

Regional Insights

North america: dominant region with 7.82% market share

North America infusion pumps market share is the most significant global market shareholder and is anticipated to exhibit a CAGR of 7.82% during the forecast period. North America is a well-developed region for healthcare services and technology implementation in the healthcare system. Factors such as increasing technological advances and the rising adoption rate of medical devices for drug delivery have enabled the higher growth of the North American market. In addition, the surging prevalence of chronic illnesses, like diabetes and cancer, is boosting the demand for infusion pumps in North America. As per a report by the IDF Diabetes Atlas, the number of diabetic individuals was around 48 million in 2019, which will witness a 33% growth to reach 63 million by 2045. Most US hospitals—between 80% and 90%—use cutting-edge, creative infusion pumps. A total of 0.5 million insulin infusion pump users are available in the US, while 10% of the diabetic population in Canada uses insulin infusion pumps. Such factors drive regional market growth.

Europe infusion pumps market growth is estimated to exhibit a CAGR of 8.75% over the forecast period. European countries have some of the best healthcare services due to increasing investment by several governments and rapidly growing health awareness among citizens. The expanding geriatric population and the increasing frequency of cancer, diabetes, and other chronic illnesses drive the regional market. Similarly, the rising demand for diagnostic services and increasing healthcare expenditure fuel the acceptance of infusion pumps in Europe. The region's increasing prevalence of gastroenterology diseases and colorectal cancer is accelerating the demand for infusion pumps. In addition, technological advances in the regional market are also generating new opportunities for market growth. The shift from hospital-based to home-based healthcare services has also created a lucrative growth opportunity for suppliers of ambulatory infusion devices.

Asia-pacific: fastest growing region with the highest cagr

Asia-Pacific has the highest population density and the largest proportion of elderly people. The region's flourishing prevalence of chronic diseases is driving the demand for infusion pumps. The continuously increasing burden of diabetes and other chronic diseases in Asia-Pacific has created a new opportunity for home healthcare infusion services. Rental and refurbished infusion pumps are commonly available in the Asia-Pacific region, which is expected to drive the adoption rate of infusion pumps in hospitals and outpatient care centers. Likewise, the increasing adoption of smart infusion pumps and the rising number of new product launches of technologically advanced infusion pumps are driving market growth. The rising acceptance of smart infusion pumps in hospitals and the growing demand for ambulatory infusion pumps are triggering the demand for infusion pumps.

Latin America is a developing region with a positive growth rate for healthcare services and solutions. Factors such as the expanding aging population and the soaring prevalence of chronic diseases drive the demand for the infusion pumps market in Latin America. Similarly, new product launches, technological advances, and the rise in demand for outpatient services and connected devices will drive the adoption of infusion pumps in the region. In 2020, the aging population accounted for nearly 8% of the total population. The population aged 65 and over will grow at a rate of 17.6% by 2050 and 30% by the end of the century. The increasing geriatric population is also augmenting the demand for healthcare services. Likewise, transitioning from hospitalization to home-based care and outpatient infusion services will drive market growth.

The Middle East and Africa is a developing region in the world. The increase in healthcare investment through FDI and initiatives to improve healthcare services have created tremendous opportunities for vendors of healthcare services. The rapidly expanding aging population and increasing burden of chronic diseases, such as diabetes, drive the regional market. Furthermore, the rising frequency of surgical procedures is accelerating the demand for infusion pumps in the region. In 2018, nearly 70% of premature deaths were attributed to chronic diseases. The increasing burden of chronic diseases and pain management has accelerated market growth.

Infusion Pumps Market Segmentation Analysis

By products

The market is segmented into insulin infusion pumps, large volume infusion pumps, syringe infusion pumps, enteral feeding pumps, and others. The insulin infusion pump segment owns the highest market share and is estimated to exhibit a CAGR of 8.23% during the forecast period. Insulin infusion pumps are used for continuous insulin delivery to a diabetic patient for a whole day. Insulin infusion pumps are wearable devices that a person can easily carry. These devices are probably used for type 1 diabetes care and reduce the risk of multiple insulin dosages by providing continuous insulin delivery. Wearable insulin infusion pumps also maintain the sugar levels in the human body. Such factors are expected to generate a higher demand for insulin infusion pumps. As per the American Diabetes Association, a 30%–40% surge in the type 1 diabetes patient population in recent years has propelled the demand for insulin. Increasing demand for insulin and rapidly increasing acceptance of insulin infusion pumps by healthcare professionals to treat diabetic patients have positively influenced the use of insulin infusion pumps.

By technology

The market is bifurcated into traditional infusion pumps and specialty infusion pumps. The traditional infusion pumps segment dominates the global market and is expected to exhibit a CAGR of 9.17% over the forecast period. Traditional infusion pumps are used for long-term home care and mobile care settings. These infusion pumps are used for drug administration procedures in mobile, ambulatory, and stationary environments. The increasing number of hospitals, ambulatory service centers, outpatient care centers, and infusion centers drive the demand for traditional infusion pumps. In addition, traditional infusion pumps can be classified into syringe and large-volume infusion pumps. These infusion pumps are mostly used to administer antibiotics, chemotherapy medications, pain medications, hydrating fluids, and other drugs.

By usage

The market is divided into stationary infusion pumps and ambulatory infusion pumps. The stationary infusion pump segment accounts for a large market share and is expected to exhibit a CAGR of 7.19% throughout the forecast period. Stationary infusion pumps are large medical devices typically used in clinical and home medical settings. They are commonly used in hospitals, clinics, and home care settings. The high infrastructure growth in the healthcare industry and acceptance of technology-based medical devices are expected to drive the adoption of stationary infusion pumps as medication infusion systems. Large-volume infusion systems deliver saline solutions, nutritional medicines, and antibiotics. In addition, stationary infusion pumps are available for rent or are sometimes refurbished. The rising demand for rental large volume infusion pumps from hospitals, nursing homes, and outpatient care centers is fuelling the demand for stationary infusion pumps.

By application

The market is divided into diabetes, oncology, gastroenterology, pediatric and neonatology, pain management, and others.  The diabetes segment is the most significant contributor to the market and is predicted to exhibit a CAGR of 8.23% over the forecast period. Diabetes is a common chronic condition worldwide, which affected around 463 million population in 2020. Diabetes creates a major burden in healthcare services. The surging prevalence of diabetes and the growing demand for insulin infusions are fuelling the adoption rate of insulin infusion pumps. In addition, factors such as the expanding aging population, increasing life expectancy, and the rising diabetic population are major drivers for implementing infusion pumps in diabetes care. Technological advances in insulin infusion pumps will also drive market growth during the forecast period.

By end-users

The market is divided into hospitals, home healthcare, nursing homes, and others. The hospital segment is the largest revenue contributor to the market and is expected to exhibit a CAGR of 7.35% over the forecast period. In hospitals, infusion pumps are a key tool for patient care in drug delivery. As per the American Society of Health-System Pharmacists (ASHP), the acceptance rate of smart infusion pumps increased from 44% to 73% between 2007 and 2014. Similarly, in 2019, the increasing acceptance of smart infusion pumps in small and larger hospitals witnessed a rapid surge. Infusion pumps are crucial to the safe administration of drugs in healthcare settings. Medication errors are reduced by infusion pumps, which can have other benefits. Infusion pumps are also used in clinical settings because they guarantee correct medicine delivery through programmed constant-rate drug delivery and 100% absorption bioavailability.

Recent Developments

• April 2023- Eitan Medical, a world leader in advanced infusion therapy and drug delivery solutions with dependable innovations that place patients at the center of care, announced the launch of Avoset™, its new cutting-edge, connected infusion multi-therapy ambulatory infusion system.

• June 2023- B. Braun Medical Inc. (B. Braun), a pioneer in smart infusion therapy, announced the release of DoseTrac® Enterprise Infusion Management Software, the next generation of infusion management software. To better understand their infusion pump fleet and related data, companies can use a combination of real-time views and retrospective reporting options provided by this new software.